Modeling Pathologic Response of Esophageal Cancer to Chemoradiation Therapy Using Spatial-Temporal 18F-FDG PET Features, Clinical Parameters, and Demographics

This publication has 27 references indexed in Scilit:

• Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
• Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer
  Radiotherapy and Oncology, 2012
• Outcomes of Patients With Esophageal Cancer Staged With [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection?
  Journal of Clinical Oncology, 2010
• Tumor heterogeneity: Causes and consequences
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
• From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
  Journal of Nuclear Medicine, 2009
• ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
  Journal of Nuclear Medicine, 2009
• Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781
  Journal of Clinical Oncology, 2008
• Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET
  Biostatistics, 2005
• Optimal number of features as a function of sample size for various classification rules
  Bioinformatics, 2004
• Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer
  The Annals of Thoracic Surgery, 2004